Advertisement
YOU ARE HERE: LAT HomeCollectionsSterling Winthrop Inc
IN THE NEWS

Sterling Winthrop Inc

FEATURED ARTICLES
BUSINESS
May 3, 1994 | From Reuters
Eastman Kodak Co. fueled speculation late Monday that it will sell all or parts of its Sterling Winthrop drug group by saying it would make a major announcement early today. Kodak gave no details and declined to elaborate beyond a two-sentence release alerting Wall Street to a "significant announcement" this morning. Analysts said Sterling could be a candidate for sale, especially after a sharp rise in drug stocks propelled by news Monday that Roche Holding Ltd. bid $5.3 billion for Syntex Corp.
ARTICLES BY DATE
BUSINESS
May 3, 1994 | From Reuters
Eastman Kodak Co. fueled speculation late Monday that it will sell all or parts of its Sterling Winthrop drug group by saying it would make a major announcement early today. Kodak gave no details and declined to elaborate beyond a two-sentence release alerting Wall Street to a "significant announcement" this morning. Analysts said Sterling could be a candidate for sale, especially after a sharp rise in drug stocks propelled by news Monday that Roche Holding Ltd. bid $5.3 billion for Syntex Corp.
Advertisement
BUSINESS
October 3, 1994 | From Associated Press
In an unusual alliance between a drug company and a nonprofit health organization, the makers of Tylenol and the Arthritis Foundation have launched a line of pain relievers aimed at the 40 million people who suffer from the crippling disease. The agreement gives the foundation $1 million a year for research, and gives Johnson & Johnson a firmer foothold in the $2.5-billion analgesic market. Tylenol, its only product in the category, is the top seller, with a market share of 33%.
HEALTH
January 24, 2000 | From Associated Press
The viruses responsible for most colds and meningitis are icosahedrons. But that is just one of the things no one knew in the early 1980s when the search began for a cure. Icosahedrons? For the non-geometry whizzes among you, that's a 20-sided solid. The quest for the drug that eventually became pleconaril started the old-fashioned way, with no clue to what rhinoviruses and enteroviruses looked like. Chemists at Sterling Winthrop Inc.
BUSINESS
December 28, 1994 | From Associated Press
A judge Tuesday rebuffed the makers of Advil, who had sought to quash advertising claims for Aleve, a fast-rising competitor. The judge complained that the mountains of conflicting claims he had to read about the two painkillers had left him with a "monumental headache." U.S. District Judge Nicholas H. Politan rejected the contention that Aleve's distributor, Procter & Gamble Co., deliberately intended to mislead consumers.
BUSINESS
May 9, 1994 | From Reuters
The recent flurry of restructurings in the drug industry has fueled speculation that two chemical giants--Monsanto Co. and Dow Chemical Co.--may seek to shed their drug units. Analysts said Roche Holding Ltd.'s $5.3-billion acquisition last week of Syntex Corp. may have restored luster to drug firms' values, which have been tarnished by fears that health care reform could put a cap on their earnings. And Eastman Kodak Co.'s decision last Tuesday to sell its Sterling Winthrop Inc.
BUSINESS
September 6, 1996
Elizabeth A. Gorbett-Frost has been appointed vice president of finance and administration for Techniclone International Corp., a Tustin biotechnology company engaged in the research and development of drug delivery systems. She will oversee human resources and financial management. Gorbett-Frost joined the company from Deloitte & Touche LLP, where she was partner-in-charge of the Life Sciences Industry Group in the Costa Mesa office.
CALIFORNIA | LOCAL
October 5, 1994 | THOMAS H. MAUGH II, TIMES MEDICAL WRITER
A new genetically engineered drug could increase the likelihood of surviving severe head injury by as much as 20%, researchers said this week. The new treatment could spell the difference between a job and independent living and life in a coma, or even death, for as many as 50,000 Americans each year, Dr. J. Paul Muizelaar of Wayne State University in Detroit told the Congress of Neurological Surgeons in Chicago on Monday.
BUSINESS
September 7, 1994 | From Times Staff and Wire Reports
Eastman Kodak Co. will sell its Clinical Diagnostics unit, a major worldwide supplier of diagnostic products, to health care products giant Johnson & Johnson for $1 billion in cash, the companies said Tuesday. The combination with Johnson & Johnson's Ortho Diagnostic Systems would create the third-largest maker of diagnostic products, with about $1 billion in annual sales.
BUSINESS
June 24, 1994 | From Times Wire Services
A rout in technology issues pushed Wall Street lower Thursday, leading analysts and traders to worry that the entire market may be poised for a deeper selloff. However, bonds and the dollar were steady while commodity prices continued to tumble, taking a key inflation index lower for the fourth straight day. The Dow Jones industrial average, which had shed 103 points in three sessions before recovering 16.80 points Wednesday, closed down 25.68 at 3,699.09.
Los Angeles Times Articles
|